Pfizer acquires Park City's Arena Pharmaceuticals in $6.7B deal
New York City-based pharmaceutical giant Pfizer Inc. has announced that it will acquire Arena Pharmaceuticals of Park City. Arena is a clinical-stage company developing potential therapies for the treatment of several immuno-inflammatory diseases. Under the terms of the…